Eric Harvill All publications ( 19 ) Wolfe DN. Kirimanjeswara GS. Goebel EM. Harvill ET. Comparative role of immunoglobulin A in protective immunity against the Bordetellae. 2007 Sep. Infect Immun. 75(9):4416-22. Wolfe DN. Mann PB. Buboltz AM. Harvill ET. Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxin. 2007 Oct 15. J Infect Dis. 196(8):1228-36. Wolfe DN. Goebel EM. Bjornstad ON. Restif O. Harvill ET. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. 2007 Oct. Infect Immun. 75(10):4972-9. Gopinathan L. Kirimanjeswara GS. Wolfe DN. Kelley ML. Harvill ET. Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. 2007 Apr. Microbes Infect. 9(4):442-8. National Center for Research Resources National Institute for Biomedical Imaging and Bioengineering National Institute of Allergy and Infectious Diseases Pilione MR. Agosto LM. Kennett MJ. Harvill ET. CD11b is required for the resolution of inflammation induced by Bordetella bronchiseptica respiratory infection. 2006 May. Cell Microbiol. 8(5):758-68. Public Health Service Pilione MR. Harvill ET. The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. 2006 Feb. Infect Immun. 74(2):1043-9. National Institute of Allergy and Infectious Diseases Wolfe DN. Kirimanjeswara GS. Harvill ET. Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. 2005 Oct. Infect Immun. 73(10):6508-13. National Institute of Allergy and Infectious Diseases Kirimanjeswara GS. Mann PB. Pilione M. Kennett MJ. Harvill ET. The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. 2005 Dec 1. J Immunol. 175(11):7504-11. National Institute of Allergy and Infectious Diseases Kirimanjeswara GS. Agosto LM. Kennett MJ. Bjornstad ON. Harvill ET. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. 2005 Dec. J Clin Invest. 115(12):3594-601. National Institute of Allergy and Infectious Diseases Mann PB. Wolfe D. Latz E. Golenbock D. Preston A. Harvill ET. Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. 2005 Dec. Infect Immun. 73(12):8144-52. Public Health Service National Institute of Allergy and Infectious Diseases Bjørnstad ON. Harvill ET. Evolution and emergence of Bordetella in humans. 2005 Aug. Trends Microbiol. 13(8):355-9. National Institute of Allergy and Infectious Diseases Elder KD. Harvill ET. Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. 2004 Oct. Infect Immun. 72(10):5919-24. National Institute of Allergy and Infectious Diseases Mann PB. Elder KD. Kennett MJ. Harvill ET. Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. 2004 Nov. Infect Immun. 72(11):6650-8. National Institute of Allergy and Infectious Diseases Pilione MR. Pishko EJ. Preston A. Maskell DJ. Harvill ET. pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. 2004 May. Infect Immun. 72(5):2837-42. Public Health Service Mann PB. Kennett MJ. Harvill ET. Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. 2004 Mar 1. J Infect Dis. 189(5):833-6. Pishko EJ. Kirimanjeswara GS. Pilione MR. Gopinathan L. Kennett MJ. Harvill ET. Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. 2004 Jan. Eur J Immunol. 34(1):184-93. Pishko EJ. Betting DJ. Hutter CS. Harvill ET. Bordetella pertussis acquires resistance to complement-mediated killing in vivo. 2003 Sep. Infect Immun. 71(9):4936-42. Burns VC. Pishko EJ. Preston A. Maskell DJ. Harvill ET. Role of Bordetella O antigen in respiratory tract infection. 2003 Jan. Infect Immun. 71(1):86-94. Kirimanjeswara GS. Mann PB. Harvill ET. Role of antibodies in immunity to Bordetella infections. 2003 Apr. Infect Immun. 71(4):1719-24.